AVTX holders · GOLDMAN SACHS GROUP INC 13F · AVTX stock

GOLDMAN SACHS GROUP INC Avalo Therapeutics Inc (AVTX) 13F holding

GOLDMAN SACHS GROUP INC reported 60,106 AVTX shares valued at $897.4K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest AVTX 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the AVTX holders table.

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.